Andrew Retter

CIK: 0002015252

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VNRX

VOLITIONRX LTD

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

VNRX
VOLITIONRX LTD
Nov 1, 2025
Tax Payment(F)
Direct
4.6K shares at avg. $0.43$2K
VNRX
VOLITIONRX LTD
Aug 15, 2025
Award(A)
Direct
19.5K shares-
VNRX
VOLITIONRX LTD
Aug 1, 2025
Tax Payment(F)
Direct
6.1K shares at avg. $0.64$4K
VNRX
VOLITIONRX LTD
Jul 1, 2025
Tax Payment(F)
Direct
4.4K shares at avg. $0.77$3K
VNRX
VOLITIONRX LTD
Jun 1, 2025
Tax Payment(F)
Direct
4.6K shares at avg. $0.50$2K
VNRX
VOLITIONRX LTD
Jun 1, 2025
Award(A)
Direct
13.1K shares-
VRNX
VOLITIONRX LTD
May 1, 2025
Tax Payment(F)
Direct
3.9K shares at avg. $0.49$2K
VNRX
VOLITIONRX LTD
Mar 1, 2025
Award(A)
Direct
10.1K shares-
VNRX
VOLITIONRX LTD
Dec 1, 2024
Award(A)
Direct
9.4K shares-
VNRX
VOLITIONRX LTD
Sep 1, 2024
Award(A)
Direct
9.8K shares-

		Type	Shares	Price		Ownership
Nov 1, 2025	VNRX VOLITIONRX LTD	Tax Payment(F)	4,588	$0.43	$1,991	Direct
Aug 15, 2025	VNRX VOLITIONRX LTD	Award(A)	19,524	-	-	Direct
Aug 1, 2025	VNRX VOLITIONRX LTD	Tax Payment(F)	6,142	$0.64	$3,931	Direct
Jul 1, 2025	VNRX VOLITIONRX LTD	Tax Payment(F)	4,401	$0.77	$3,380	Direct
Jun 1, 2025	VNRX VOLITIONRX LTD	Tax Payment(F)	4,598	$0.50	$2,313	Direct
Jun 1, 2025	VNRX VOLITIONRX LTD	Award(A)	13,069	-	-	Direct
May 1, 2025	VRNX VOLITIONRX LTD	Tax Payment(F)	3,913	$0.49	$1,908	Direct
Mar 1, 2025	VNRX VOLITIONRX LTD	Award(A)	10,142	-	-	Direct
Dec 1, 2024	VNRX VOLITIONRX LTD	Award(A)	9,365	-	$0	Direct
Sep 1, 2024	VNRX VOLITIONRX LTD	Award(A)	9,784	-	$0	Direct

1-10 of 10 transactions

About Retter Andrew

Retter Andrew (SEC CIK 0002015252) files insider reports with the SEC as Chief Medical Officer of VOLITIONRX LTD (VNRX).

Signal8 holds 9 ownership filings by Retter Andrew, all Form 4s, filed between Sep 4, 2024 and Nov 4, 2025. Those filings report 10 transactions, from Sep 1, 2024 to Nov 1, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Retter Andrew's filings is in HENDERSON, NV.

Recent filings by Retter Andrew

Nov 1, 2025: Tax withholding of VNRX shares (Form 4, code F).
Aug 15, 2025: Grant or award of VNRX shares (Form 4, code A).
Aug 1, 2025: Tax withholding of VNRX shares (Form 4, code F).
Jul 1, 2025: Tax withholding of VNRX shares (Form 4, code F).
Jun 1, 2025: Tax withholding of VNRX shares (Form 4, code F).

Other insiders filing for VOLITIONRX LTD (VNRX)

Batchelor Ann-Louise, Group Chief Marketing Officer
Forterre Gael, Chief Commercial Officer
Rootsaert Rodney Gerard, Secretary
Micallef Jacob Vincent, Chief Scientific Officer
Plummer Nicholas, GC - Volition Diagnostics
Rubin Ethel, Director

How to read Form 4 transaction codes